FindTrial
Sign In

A multi-center investigation study on the application of new oral anticoagulants in China

A multi-center investigation study on the application of new oral anticoagulants in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031909
Enrollment
Unknown
Registered
2020-04-14
Start date
2020-04-16
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All indications for new oral anticoagulants

Interventions

Case series:N/A

Sponsors

Union Hospital Affiliated to Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who have used noac (rivaroxaban, dabigatran, apixaban or eduxaban); 2. Patients with detailed basic medical record information and diagnosis and treatment process; 3. Patients with definite purpose, dosage and course of medication.

Exclusion criteria

Exclusion criteria: Patients with incomplete medication information.

Design outcomes

Primary

MeasureTime frame
Utilization rates in each clinical department;Medication evaluation results;Effecacy and safety outcomes;Correlation analysis of adverse reactions;Compliance analysis;Drugs interaction analysis;Risk factors analysis;Construction of risk assessment model of bleeding and thrombosis;—

Countries

China

Contacts

Public ContactJinhua Zhang

Union Hospital Affiliated to Fujian Medical University

pollyzhang2006@126.com+86 13306912381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026